News & Press Releases

Select category
Filter by

Press contact: 

Burson-Marsteller

Tel: +39 02 721431.1

Antonella Violante: antonella.violante@bm.com

Alessia Quaglio: alessia.quaglio@bm.com

 

01/02/2016 Stevanato Group acquires 65% of the Danish SVM Automatik and strengthens its leadership in the Engineering Systems division

Stevanato Group, international leader in cartridges production for diabetes treatment, glass containers for pharmaceutical use, glass tube converting machines and visual inspection systems for the pharmaceutical industry, strengthens its Engineering Systems division by acquiring the 65% of the Danish SVM Automatik, a company specialized in assembly, packaging machines and serialization solutions headquartered in Silkeborg, Denmark. 

26/11/2015 Stevanato Group: 17,4% revenue increases in the first nine months of 2015

The Group, leader in manufacturing cartridges for insulin and glass primary packaging for the pharmaceutical industry as well as in the production of complete forming and converting machines for glass products, continues its double digit growth.

Stevanato Group registered revenue for 237,4 million Euro at the end of the third quarter 2015, with a 17,4% increase from the same period of 2014, with relevant increases in both divisions: Pharmaceutical Systems and Engineering Systems.

16/06/2015 Stevanato Group gets the prize MEDIASTARS | The Technical Award for Italian Advertising

The Stevanato Group website was awarded the first prize MEDIASTARS, the Technical Award for Italian Advertising in the "Internet - Corporate Websites" section.

The awards ceremony of the XIX edition winning projects of the Mediastars prize took place on 12th June 2015. It is one of the most prestigious prizes at Italian level for the realization of Advertising, Corporate Design and Multimedia Communication Campaigns.

18/03/2015 STEVANATO GROUP KEEPS GROWING: IN 2014 REVENUES AT 285 MILLION EURO (+18,7%)

The Group, leader in manufacturing cartridges for insulin and glass primary packaging for the pharmaceutical industry as well as in the production of complete forming and converting machines for glass products, continues its double digit growth.

The Group, which has approved the pre-closing data of 2014, registered a consolidated turnover of 285 million euro, with an increase of 18,7% compared to the 240 million euro of 2013. Both divisions (Pharmaceutical Systems e Engineering Systems) have been characterized by a good performance in all the reference markets.

15/09/2014 Stevanato Group grows also in the second quarter 2014: Revenues +22,2%

The Group specialized in the production of glass pharmaceutical packaging and technology for the glass tube forming and control, reaches 134,1 million Euro revenues in the second quarter 2014, +22,2% from the same period in 2013. EBITDA is 32,1 million Euro.

26/06/2014 Stevanato Group Invests 27 Million Euro (288 Million Rmb) In China, Inaugurating Its New Production Plant In Zhangjiagang

Stevanato Group (Piombino Dese - Padua, Italy), an international leader in the production of cartridges for insulin and glass containers for pharmaceutical use through its Ompi brand, today strengthened its presence in Asia Pacific by officially inaugurating the new Ompi of China production plant in Zhangjiagang (China). 

08/05/2014 New corporate identity for Stevanato Group in line with the company's growth and international expansion objectives

In order to meet the demands of a constantly evolving market and accompany the Group's evolution and mission, Stevanato Group—international leader in the production of insulin cartridges and glass containers for pharmaceutical use and in technology for glass tube forming machines and visual inspection machines—updates its corporate identity.

14/04/2014 STEVANATO GROUP ANNOUNCES THE ENTRANCE OF FABIO BUTTIGNON IN THE BOARD OF DIRECTORS

Stevanato Group, international leader in the production of insulin cartridges and glass containers for pharmaceutical use, in technology for glass tube forming machines and visual inspection machines, announces that Prof. Fabio Buttignon joined the Company as member of the Board of Directors.

25/09/2013 Stevanato Group announces the entrance of Fabrizio Bonanni in the Board of Directors

Stevanato Group announces that Dr. Fabrizio Bonanni joined the Company as member of the Board of Directors. Dr. Bonanni boasts a large experience in the biopharmaceutical field, thanks to his previous involvement in two large American multinational companies.

02/07/2013 Stevanato Group acquires InnoScan

Stevanato Group strengthens its market position by acquiring the majority stake of InnoScan, a Danish manufacturer of state of the art high-speed inspection machines for the pharmaceutical industry.